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ROBUSTNESS AND EVOLVABILITY OF THE B CELL
MUTATOR MECHANISM
PATRICIA THEODOSOPOULOS AND TED THEODOSOPOULOS
Abstract. We present a model that considers the maturation of the antibody
population following primary antigen presentation as a global optimization
problem [TT99]. The trade-off that emerges from our model describes the
balance between the safety of mutations that lead to local improvements in
affinity and the necessity of the system to undergo global reconfigurations in
the antibody’s shape in order to achieve its goals, in this example of fast-paced
evolution. The parameter p which quantifies this trade-off appears to be itself
both robust and evolvable. This parallels the rapidity and consistency of the
optimization operating during the biologic response. In this paper, we explore
the robust qualities and evolvability of this tunable control parameter, p.
1. Introduction
The challenge that faces the immune system is the combinatorial complexity of
antigenic agents and the need to reliably, rapidly and consistently respond with
the available repertoire. This entails a considerable expense of energy to the or-
ganism and risk, in the form of potentially creating a malignant or autoimmune
state. These qualities make affinity maturation well suited to an approach through
mathematical modeling. The purpose of our model is to study the phenomenon
of affinity maturation of the humoral immune response as a global optimization
problem on a rugged affinity landscape. Affinity in our model is defined as the
probability of antigen and antibody existing in the bound state. Movement on the
affinity landscape occurs through mutations in the immunoglobulin (Ig) gene that
produce changes in configuration of the Ig molecule.
This modeling approach aims not only to replicate some of the observed behaviors
of the system, but also to suggest a more fundamental property of the system that
might be underpinning the observed behavior. This property is embodied in a
control parameter that the model utilizes to explore the landscape and produce a
consistent and adequate response in a limited period of time.
This parameter is intended to capture the trade-off between local steps on the
landscape of affinity that produce small structural changes and potentially produce
only incremental increases in affinity, versus global jumps that might produce large
changes in antigen combining site configuration. These global jumps, although
risky, allow the system to avoid becoming trapped in local optima and may permit
faster exploration of the landscape and faster attainment of a higher affinity.
The model system exhibits the qualities observed in the biologic system, which
include a fast and robust response optimization despite variability in the landscape
structure which reflect novel antigenic challenges. The model system also allows
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for the inclusion of other observed behaviors of the biologic system such as the
repertoire shift [FJR98, NKJ+98, DF98, BRZ+98]. The presumed instantiation of
the trade-off parameter is in the genetic code, thus making it subject to the forces
of evolution and selection as well. This paper begins with a brief review of the
dynamics of the model and the evolutionary landscape. We subsequently focus on
the importance of p, and its relation to performance robustness, and the affinity
threshold for terminating the hypermutation process. We also attempt to clarify
the observed evolution of p.
2. The Model
The model attempts to delineate a selection-based trade-off that underlies the
evolution of affinity-matured antibodies. We take into consideration both the con-
tribution of the microenvironment in the germinal center as well as the intrinsic
properties of antigen– antibody interactions. The main purpose of the model is
to elucidate the drivers behind the apparently complex behavior of the immune
system and develop a qualitative understanding of what makes the system work so
efficiently. The model does not attempt to represent the detailed molecular com-
plexity of the system. Rather, we wish to model the qualitative aspects of the
system that lead to the observed large scale behaviors of the system. Through this
exercise, we hope to gain an appreciation and understanding of the more funda-
mental mechanisms that drive the system so effectively towards its goal.
2.1. Local Steps versus Global Jumps. The model we present attempts to
capture the biological “trade-off” that controls the mutation process and enables
the rapid generation of high affinity antibodies. One might understand this trade-
off in terms of the balance between mutations that produce only local changes in
the conformation and are therefore more likely, although not exclusively, to lead
to incremental changes in the affinity, versus those mutations that produce global
jumps in shape space and therefore enable the system to avoid becoming trapped
in local optima of the affinity landscape.
The na¨ıve repertoire usually produces antibodies with affinities on the order
of 105M−1 and the hypermutation process results in antibodies with a range of
affinities from 106 − 108M−1 within a period of days (corresponding to around
10− 20 generations) from a finite number of clones [Elg96]. The traditional treat-
ment of affinity changes and mutational studies favors the idea that the mutation
process enables the selection of clones that undergo a stepwise increase in affinity
[BCD+95, Nos92, BSPS+92] – an additive effect of changes that create new hydro-
gen bonds or new electrostatic or hydrophobic interactions between the residues
of the antigen epitope and the antibody variable region, and can alter these in-
teractions with associated solvent molecules [CW97, AWL98, BCD+95]. However,
it is observed that all codon changes cannot be translated into stepwise energetic
changes [CW97]. In the literature, affinity increases are sometimes understood as
improved kinetics, often translated into a lower Koff or a higher Kon, although
which kinetic component dominates during different phases of the hypermutation
process is unclear [WPW+97, AWL98, NTM+98, BN98, FM91]. Other mutations
may be neutral from an affinity perspective, but may actually be permissive of
subsequent affinity enhancing mutations [CK00, FAFS+99, HSF96].
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Models of affinity changes as stepwise energetic improvements in the selected
antibodies have also led to the idea that the antibody conformation evolves like-
wise. The progression to a higher affinity conformation conformation occurs at the
expense of entropy, in exchange for a decrease in enthalpy and a commensurate
increase in affinity [WPW+97]. Since we cannot reliably observe the process, we
cannot presume that this stepwise search is what is always functioning in the ger-
minal center. Our modeling paradigm predicts that the observed rapid elaboration
of high affinity antibodies through the germinal center reaction could only occur if
the system experiences occasional large jumps in order to more efficiently sample
the conformational landscape.
It is likely that the optimization takes advantage of bias in the V gene code and
that subsequent mutations would attempt to create flexibility in some regions to
facilitate docking while other regions are optimized to maximize antigen-antibody
interactions and stabilize binding for appropriate feedback and signaling to occur
[FAFS+99, GEBL98]. The positions of positively selected mutations show that
replacement mutations occur preferentially in the complementarity determining re-
gions (CDRs) versus the intervening framework regions (FRW)[FDL99a, FDL99b].
The FRW is often described as being very sensitive to replacement mutations, but it
appears now that they too can tolerate a certain number of replacement mutations,
and that the CDRs may alternately possess a sensitivity to mutations through the
coding structural elements [WRW+98]. The greatest diversity is seen in CDR 3,
which typically has the most contact residues with the antigen, while CDR 1 and
2 usually comprise the sides of the binding pocket [JMS+95].
Studies comparing germline diversity with hypermutated V genes show that
the amino acid differences introduced by mutation were fewer than the underlying
diversity of the primary repertoire. These studies further suggest that the CDR 1
and 2 residues, which are more conserved in the na¨ıve repertoire and often create
the periphery of the binding site, are favored for mutation. Alternatively, the more
diverse residues represented in the na¨ıve repertoire are generally not as favored for
mutation [DFBL98]. Perhaps there can even be identified critical residues where
mutation might produce large conformational changes.
Although certain point mutations in critical residues may create large changes
in conformation, additional mechanisms for global jumps may be appreciated from
evidence of receptor editing [dHvV+99] in the germinal center as well as the relative
frequency of deletions and insertions. [KGF+98]. These types of alterations would
also be expected to represent global jumps on the affinity landscape.
2.2. The Evolutionary Landscape. As mentioned earlier, we treat the affinity
maturation of the primary humoral immune response as a problem of global op-
timization. This paradigm should be contrasted with the “population dynamics”
modeling approach. The latter class of models entails the tallying of individual
immune cell types and the investigation of the transition dynamics between their
allowable states. Such models represent the emergence of affinity optimization as a
result of these cell population dynamics. In this vein, it is generally the evolution
of the average affinity in the population that is the dominant variable.
In our model the primary role is played by the order statistics (e.g. maximum)
of the affinity levels that have been achieved up to any stage of the hypermutation
process. Specifically, the size of the B cell population is exogenous to our model.
We assume that the hypermutation process is initiated via a mechanism outside the
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scope of our model. Our treatment of the hypermutation process terminates upon
the development of a desirable proportion of clones with sufficiently high affinity.
As a result of our focus on the affinity improvement steps, we measure time in a
discrete fashion by counting inter-mutation periods.
As a first step, we begin with the space of all DNA sequences encoding the
variable regions of the Ig molecules and a function on that space that models the
likelihood that the resulting Ig molecule becomes attached to a particular antigen.
This affinity function is conceptualized in a series of mappings which portray the
biochemical mechanisms involved.
To begin with, the gene in question is transcribed into RNA and subsequently
translated into the primary Ig sequence. This step describes the mapping from
the genotype (a 4–letter alphabet per site) to the sequence of amino acids making
up the Ig molecule (a 20–letter alphabet per site). The next step is the folding
of the resulting protein into its ground state in the presence of the antigen under
consideration. This step is modeled as a mapping from the space of amino acid
sequences to the three- dimensional geometry of the resulting Ig molecule1.
Finally, the protein shape gives rise to the free energy of the Ig molecule in
the presence of the antigen. The free energy in turn is used to define the asso-
ciation/dissociation constants and the corresponding Gibbs measure which deter-
mines the likelihood of attachment. The resulting affinity is visualized as a high-
dimensional landscape, where the peaks represent DNA sequences that encode Ig
molecules with high affinity to the particular antigen.
Let X denote the space of DNA sequences encoding the VH and VL regions of
an Ig molecule. Let f be a positive, real-valued function on X , which denotes
the affinity function, as described above. Finally, consider the gradient operator
Df(x) = argminy∈N (x) f(y), where {N (x) ⊆ X , x ∈ X} describes the neighbor-
hood structure2 in X . With this notation, for each sequence x ∈ X , successive
applications of the gradient operator converge to the closest local optimum, i.e.,
there is a finite positive integer d(x) and a genotype F∗(x) ∈ X such that for all
n ≥ d(x),
Dnf(x) = Dd(x)f(x) = F∗(x).
This association partitions X into subsets that map to the same integer under d(·).
These “level sets” contain all sequences that are a fixed number of point mutations
away from their closest local optimum.
A further ingredient of our model for the affinity landscape is the relative nature
of the separation between strictly local and global optima. In practice, the global
optimum is not necessarily the goal. Instead, some sufficiently high level of affinity
is desired. This affinity threshold is generally unknown a priori. Our model allows
us to view the landscape as a function of the desired affinity threshold. We are
able to study the dependence of our model’s performance for a variety of affinity
1This concept is analogous to that of shape space in Chap. 13 of [Row94], first introduced in
[PO79] and further elaborated in [dSP92].
2In this paper we concentrate on point mutations as the mechanism for local steps and thus
the neighborhood we consider consists of all 1–mutant sequences. It has been suggested [Man90,
GM96] that more than one point mutation may occur before the resulting Ig molecule is tested
against an antigen presenting cell to determine its affinity. Our model can capture such an
eventuality by appropriately modifying the neighborhood structure to include the 2– or generally
k–mutant sequences.
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thresholds and thus investigate the trade-off between the desired affinity and the
required time.
The appreciation of strictly local versus global optima as a relative characteristic
necessitates a finer partition of the level sets. Specifically, for each level of affinity
threshold, some of the local optima in X are below it and therefore are considered
strictly local, while others are above it and are therefore considered global. This
leads to a decomposition of each level set into the part containing sequences a certain
number of steps below a strictly local optimum versus sequences whose closest local
optimum is also global because its affinity is above the desired threshold.
2.3. Optimization Dynamics. We model the dynamics of evolutionary optimiza-
tion on the affinity landscape as a Markov chain. Specifically, the chain may take
one of two actions at each time step: it may search locally to find the gradient
direction, and take one step in that direction or it may perform a global jump,
which effectively randomizes the chain. The decision between the two available ac-
tions is taken based on a Bernoulli trial with probability p: when p = 0, the chain
performs global jumps all the time while p = 1 prohibits any global jumps. Thus,
the parameter p controls the degree of randomization in the Markov chain. The
biological distinction between local search versus global jumps is realized by means
of at least three mechanisms described earlier: receptor editing, deletions/insertions
and point mutations that lead to sizeable movements in shape space.
The mathematical description of the Markov chain model described above uses
the following generator:
[G(p)φ] (x)
∆
= pφ(Df(x)) + (1− p)Eµ[φ] − φ(x),
where µ represents a global mixing measure, e.g. the uniform measure with support
spans the entire relevant sequence space. Note that we suppress the dependence
on the level of the control parameter p (e.g. writing G instead of Gp) for notational
clarity and convenience. Keep in mind though that all variables associated with this
Markov Chain will, implicitly, be functions of p. We are interested in estimating
the extreme left tail of the distribution of the exit times for the resulting Markov
chain. In particular, let
τ(M)
∆
= inf
{
k ≥ 0|Xk ∈ f
−1 ( [M,∞))
}
,
where Xk denotes the Markov chain under consideration. We are interested in
estimating the likelihood that at least one out of a population of n identical, non-
interacting replicas of the Markov chain will reach an affinity level higher than M
before time y. It should be noted that, by virtue of the discrete nature of the
Markov chain, time in this context is measured by the number of mutation cycles
experienced by the system. The probability we are looking for takes the form
P∗
(
τ(n,⌈qn⌉)(M) ≤ y
)
= 1−
⌊qn⌋∑
i=0
(
n
i
)
P∗ (τ1(M) ≤ y)
i
(1− P∗ (τ1(M) ≤ y))
n−1
,
where P∗ denotes the path measure induced by the Markov chain the index i tallies
the replica under consideration, and we use the notation X(n,m) to denote the kth
order statistic out of a sample of n independent draws from the distribution of the
random variable X . Since we are focusing our attention to the GC reaction, n is
approximately 103-105.
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2.4. Methodology. The study of the evolutionary optimization process outlined
in the previous section uses results by the second author on the covergence rates of
exit times of Markov chains [The95, The99]. The general approach for estimating
the desired tails of the exit time distributions consists of the following steps:
(i) We formulate a Dirichlet problem for G(p) on f−1 ( [M,∞ )) whose solution
provides a martingale representation of the Laplace transform of the exit
time τ(M).
(ii) We solve the resulting Dirichlet problem and compute the desired Laplace
transform as
ψ(ξ)
∆
= E∗
[
eξτ(ǫ)
]
=
(
1− peξ
)∑b
j=0 q(j)p
jejξ
1− eξ + (1 − p)eξ
∑b
j=0 q(j)p
jejξ
where E∗ denotes the expectation under P∗ starting from a µ–distributed
initial sequence. Here q(·) denotes the measure of the level sets a given
number of local steps below a global optimum (i.e. an optimum above the
desired affinity threshold), as described in the section on the Evolutionary
Landscape.
(iii) We compute the Legendre-Fenchel transform I(y) of the cumulant of τ(M)
as
I(y) =


∫ y
E∗[τ]
1 Ξ(t)dt, if y ≥ E
∗[τ ]∫ 1
y
E∗[τ]
Ξ(t)dt, otherwise
,
where Ξ(t) is the (positive or negative depending on whether y ≥ E∗[τ ] or
not) solution to
dψ
dξ
(
Ξ(t)
E∗[τ ]
)
= tE∗[τ ]ψ
(
Ξ(t)
E∗[τ ]
)
.
It turns out [The95] that, for y ≤ E∗[τ ],
P∗ (τi(M) ≤ y) ∼= exp {I(y)} .
Note that E∗[τ ] can be evaluated explicitly using the representation of the
Laplace transform. In particular, one can show after some algebra that the
expected number of generations required for a particular antibody to evolve
above-threshold affinity is given by:
E∗[τ ] =
1
(1− p)
∑b
j=0 q(j)p
j
,
which, for typical parameter values, tends to be over 10,000! What we
are after is the extreme left tail of the response time distribution, the few
antibodies in the GC population that happen to take significantly fewer
generations than average (typically between 10 and 20) to evolve above-
threshold affinities.
(iv) We estimate Ξ(t) by performing a Taylor expansion of the cumulant of
τ(M) at −∞, yielding
dψ
dξ
(logλ) =
∞∑
i=1
ciλ
i
i!
,
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−10−1
−10−2
−10−3
Number of generations (t)
Ξ(
t)
Figure 1. Approximation scheme for Ξ(t) as tց 0+ (incidentally,
for this example, E∗[τ ] = 16, 473)
as λց 0+. Inverting the polynomial on the right-hand side we obtain the
general approximation form
Ξ(t) ∼= −t−1,
which holds remarkably well as long t ≥ 10, i.e. at least ten generations.
For t = 1, 2, . . . , 9 we evaluate Ξ(t) numerically, by solving the associated
polynomial. Figure 1 shows an example of this approximation scheme.
2.5. Note on random variables. Three distinct sources of randomization play a
central role in our model. In an effort to allay confusion, we want to be particularly
clear about our use of random variables in the description of our results.
Firstly, there is a dimension of randomness arising fundamentally from the ran-
dom nature of the mutations during the immune maturation process. We refer to
different instances of this process as “mutation scenarios” and usually we reserve
the letter ω to signify them. The parameter p introduced earlier serves to control
this dimension of randomness.
Secondly, there is variability within the population of antibodies that make up a
particular germinal center under investigation. We will generally only be concerned
with the proportion of the antibody population from a given germinal center that
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shares a common property, rather than the explicit identification of any one anti-
body out of the population. Thus, we use the letter q to denote proportions of this
population, rather than denoting random elements explicitly.
Thirdly, there is a dimension of randomness arising from the unknown genotype
of the antigenic challenge. As described above, each antigen generates a different
affinity landscape within which the antibody evolution process occurs. We typically
reserve the letter z to denote a random instance of an affinity landscape (resulting
from a random antigen).
As will become apparent in the following sections, our results typically involve
properties of appropriately chosen quantiles of the “response distribution”, i.e. the
random variable measuring the time (in mutation cycles) until a given proportion of
the antibodies populating the germinal center under investigation reaches an affinity
for the antigen under investigation above a given threshold. Mathematically, these
are quantiles of a stopping time under the probability measure of ω. As such,
these objects are still random variables, relative to the choice of a random antigen
and resulting affinity landscape z. Later we proceed to describe properties of the
response distribution relative to randomly chosen antigens. Mathematically, these
are quantiles with respect to the probability measure of z.
We generally use analytic estimates to study the properties of the distribution
of ω while reserving simulation techniques for the properties of the distribution of
z. For instance, Figures 2 and 3 are generated analytically, while Figures 4, 5 and
6 are generated by repeating the analytical estimates for 1,000 randomly generated
affinity landscapes.
3. Overview of Results
The setting described above was used in [TT99] to obtain estimates on the re-
sponse characteristics of the immune system and its sensitivity to the amount of
mixing in the MC. More concretely, let L(a, b, c) denote the set of affinity land-
scapes, parameterized by
• the maximum number of affinity level sets a in a strictly local maximum
hill,
• the maximum number of affinity level sets b in a global maximum hill, and
• the ratio c of the size of the affinity level sets that belong to the attraction
basin of a strictly local maximum versus those that belong to the global
maximum attraction basin.
Also, let τ (ω, z, p, q) denote the random number of mutations that it takes under
mutation scenario ω for a proportion q of the population of antibodies in a particular
GC to reach the desired level set in the random affinity landscape z ∈ L(a, b, c)
for some a, b and c, while performing global jumps with probability 1 − p. This
is a generalization of the stopping time τ(M) defined earlier in the section on
Optimization Dynamics. We now suppress the dependence of the stopping time on
the affinity threshold M , focusing instead on the other variables that influence it.
We can summarize the results of [TT99] as follows:
(1) For a population N of a few tens of thousands and biologically justifiable
values of a, b and c (see for example [Elg96, Man90, SM99]), for any p above
some minimum value and for all z, Pr
(
τ
(
·, z, p,N−1
)
≤ y
)
exhibits a sharp
cutoff [OP97]
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(2) Let R (c1, z, p, q) denote the c1-quantile of the distribution of τ . Then, for
any choice of c1 and for all z, R
(
c1, z, ·, N−1
)
exhibits a unique minimum
at a p∗ < 1.
(3) The graph of the mean and standard deviation of R
(
c1, ·, p,N−1
)
over
randomly generated landscapes has two branches, one for low p and one for
high p, that we designate “liquid” and “solid” state respectively.
(4) Let us begin the MC with a randomly chosen value of p and allow p to
evolve taking incremental steps after each antigenic response, with a bias
towards the direction of the optimal value of p for the most-recently resolved
antigenic affinity landscape. Under these conditions, the value of p evolves
autonomously to a narrow range (strictly less than 1) around the optimal
values of the majority of affinity landscapes (“optimal range”).
What we aim in the current paper is to explore three of these areas in more
detail. Specifically, we first investigate how the cutoff behavior changes when we
require that q > N−1. We then attempt to better describe the characteristics of
our conjectured phase transition when we contrast the responses of high-p vs. low-
p MCs across randomly generated landscapes. Finally, we define a more realistic
version of the evolving p model and show that the system continues to converge to
a value of p in the optimal range.
4. Evolving Population of Antibodies
We begin by studying the propagation of affinity maturation across the pop-
ulation of antibodies in a GC. Figure 2 displays the cumulative probability that
a proportion q of the N antibodies populating the GC have reached the desired
affinity threshold after an increasing number of accumulated mutations. The cutoff
observed in [TT99] for the case q = N−1 (requiring a mere five mutations to boost
the probability that at least one antibody in the GC has reached the threshold
affinity from below 10% to over 90%) becomes substantially attenuated as we in-
crease q. Already when we ask that at least 25 different mutant antibodies, out of
the approximately 50,000 assumed to populate the GC, reach the affinity threshold,
the sharp cutoff has been replaced by a gradual transition that requires more than
30 mutations to affect the same increase in cumulative probability.
Furthermore, we see in Figure 3 that the required number of mutations for qN
antibodies to reach the affinity threshold increases approximately linearly with q,
with a slope that itself increases with the desired confidence level. In particular,
for every affinity landscape z ∈ L(a, b, c) and 0 < p, c1 < 1, there exists a β > 0
such that
R (c1, z, p, q1)− β
R (c1, z, p, q2)− β
=
q1
q2
.
As we would expect from Figure 2, ∂
2R
∂q∂c1
> 0. Thus, if we want to double the
proportion of a GC’s antibodies that reach the affinity threshold we have to wait
twice as long, while the sensitivity of the response time to the desired confidence
level increases as we increase the target proportion of antibodies.
5. Regularities across affinity landscapes
5.1. First two moments. We now look at how the quantiles of the response time
R behave when we vary the affinity landscape. To effect this, we pick uniformly m
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Figure 2. Convergence of Pr (τ (·, z, p, q) ≤ y) as a function of y
for three different values of q, p = 0.8, a = 20, b = 10 and c = 1, 000
independent random sets of {ai}mi=1, {bi}
m
i=1 and {ci}
m
i=1 within biologically justi-
fiable ranges as we did in [TT99], and we generate a series of m affinity landscape
zi ∈ L (ai, bi, ci) respectively. Let µ (c1, p, q) and σ (c1, p, q) denote the mean and
standard deviation respectively of R (c1, z, p, q) over the induced probability distri-
bution on z.
Our first observation, shown in Figure 4, is that µ (c1, p, q) and σ (c1, p, q) both
exhibit pronounced minima as functions of p, and that the corresponding min-
imizers are almost identical. Thus, the value of p that guarantees the quick-
est average response to any antigen whose resulting affinity landscape belongs to⋃m
i=1 L (ai, bi, ci), also minimizes the variability of the response. Biologically, the
system would likely choose to remain somewhere in this optimal range since this
would give a rapid response with high likelihood of reaching threshold affinity even
for more difficult antigens, at minimum expense of resources and risk of detri-
mental mutations accumulating. This may also permit the greatest number of V
gene candidates to attempt to respond to a given antigenic challenge, optimizing
search conditions in terms of available pathways and parameters optimized on the
landscape such as energetics or kinetics.
Another way to see this effect is by graphing σ as a function of µ as in Figure 5.
As mentioned earlier in the Note on Random Variables, this figure was generated
by iterating our analytic estimates for the desirable response time quantiles as a
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Figure 3. Quantiles of τ (·, z, p, q) as a function of q for p =
0.8, a = 20, b = 10 and c = 1, 000
function of p, over different, randomly generated affinity landscapes. A 3-D graph
is first produced, mapping the first two moments of the resulting response time
distribution (with respect to the measure of z) against the corresponding values of
p. Finally, the p dimension is suppressed to focus on the relationship between the
first two moments of the response time distribution. Thus, as labeled on the graph,
points on the resulting curve are parameterized by values of p. The same holds for
Figure 6 which offers a blow-up of the region around the cusp in Figure 5.
Increasing p progressively first leads to a dramatic decrease in both the mean
response time and its variability, until we reach a narrow “critical” range of p values.
Once we increase p past this range, the response begins to deteriorate, but with
measurably lower, yet still increasing response variability. This decreased reliability
in the performance of the system in the low p values could due too frequent jumps
around the landscape, randomizing the system too frequently. This does not permit
adequate exploration of the local neighborhood. Alternately, p values above the
optimal range exhibit a more definite peak, but also show a longer tail. The system
also experiences a decline in performance, perhaps due to getting trapped in local
minima without the benefit of a higher level of randomness to escape these minima.
Furthermore, Figure 6 offers a clear indication that the sensitivity of σ to changes
in µ decreases suddenly as we move from the “low-p” to the “high-p” regime.
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Figure 4. The mean and the standard deviation of the response
times over 1,000 randomly generated landscapes are almost co-
incident (c1 = 50%, q = N
−1 and N=50,000)
5.2. Tail behavior. Our second observation has to do with the shape of Pz (R (c1, ·, p, q) ≤ y)
as a function of y. It turns out that for small values of p, the pdf of R is heavily
skewed, with protracted right tails. This shape persists qualitatively as we increase
p until about p = 0.86, at which point a transition begins which quickly snaps the
right tail and transforms the distribution to approximately uniform.
The normal probability plots in Figure 7 compare the tails of R
(
c1, ·, p,N−1
)
against the best-fit normal, i.e. N
(
µ, σ2
)
. These plots clearly show that, while R
has fat left tails irrespective of p, the right tails die out slower than the normal’s
(e−
(x−µ)2
σ2 ) for low values of p. As we increase p, the right tail is shortened until it
looks more like a uniform distribution.
In order to quantify this distributional shift, we computed the Kolmogorov-
Smirnov (KS) statistic between R
(
c1, ·, p1, N−1
)
and R
(
c1, ·, p2, N−1
)
(computed
over 1,000 randomly generated landscapes in
⋃m
i=1 L (ai, bi, ci)) while varying p1 and
p2 in (0, 1). This procedure generates a matrixK (p1, p2) which provides us with the
confidence levels to which we cannot reject the null hypothesis thatR
(
c1, ·, p1, N−1
)
and R
(
c1, ·, p2, N−1
)
come from the same distribution.
Figure 8 provides us with four cross-sections of K for increasing values of p. We
notice that for low values of p, there is more than 10% chance that R’s distributions
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Figure 5. Two regimes emerge as we vary p over a large popula-
tion of affinity landscapes
for all other low values of p are identical. This phenomenon persists until past p =
0.91. However, at some point around p = 0.98, there is a switch to R distributions
arising from high values of p, which also have a reasonably high probability of being
identical.
This behavior is seen clearly in Figures 9 and 10. Here we see indeed two “islands
of distributional stability”, one for low and one for high values of p, separated by a
“saddle-point”, itself very close to the “turning point” in the µ−σ graph in Figure
6.
A similar segregation of two regimes is seen in Figure 11 which shows the dif-
ferent scaling properties of the quantiles of R for values of p below and above a
relatively narrow critical range. Namely, over a large population of affinity land-
scapes (representing different antigenic agents) the worst-case performance of an-
tibodies exhibiting a p > 0.98 scales approximately like 11−p . This scaling changes
to approximately (1 − p)14+4 log(1−p), over a range of p that corresponds to the
saddle-point in Figure 10.
In biological terms, the system needs to ensure a consistent response within
the constraints of the available number of clones, the need for rapid response and
physical and energetic limitations. The lower p value decreases the reliability of the
response, and requires the utilization of more energy, resources and time to respond,
especially if the antigen is more complex or challenging. It would also burden the
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Figure 6. Close-up of Figure 5 showing the different slopes in the
two branches of the graph
feedback system for screening detrimental mutations. Alternately, if the p value
is too high then again we face a potentially more serious timing problem and risk
not achieving threshold affinity in a reasonable time frame. On either side of the
optimal range, the risk is present of being unable to mount an adequate response
to the antigen and optimally stimulate other immune effector functions.
6. Evolution of the control parameter p
Previously we used a hierarchical evolution model [TT99] to depict the evolving
value of p in a population, and the optimal value of p corresponding to the landscape
for each new infection. Despite starting distinctly outside the desired range, the
system converged rapidly to the desired band of p values and was stabilized within
that band. We hypothesized that the performance advantage conferred by this
range of p values outweighed the disadvantage of not reaching the optimal p required
to respond to any individual antigen.
In our current treatment of evolvability, we want to better understand how the
frequency of mutations in the control parameter p influences its steady-state dis-
tribution. We start p randomly, and allow each subsequent mutation to influence
p with a small probability. When the current value of p is far from the value of p
that minimizes the response time to the antigen we are facing, then the antibodies
will need more mutations, leading to a higher likelihood of an eventual mutation in
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Figure 7. As we increase p, the tails of R over random affinity
landscapes progress from fat to thin relative to the normal (which
is represented as a straight line in each graph)
p. One the other hand, as p approaches the optimal value for the invading antigen,
the antibodies respond more quickly, allowing less time for possible mutations to p.
From the above results, we can see that mutating p too frequently leads to
insufficient differentiation between different values of p and thus creates a more
uniform steady state distribution for p; thus too great a variability would likely be
detrimental to performance. At slower mutation rates we see that the distribution
begins to peak within the optimal range of values. This may be evidence of an
emerging time limit during the mutation process, where a B cell that has not yet
reached threshold by approximately 20 mutations is therefore more likely to mutate
p to effect a response.
From our previous results, we might also predict that the system would choose
to maintain p coded in the optimal band, but maintain the ability to mutate it
within this band to further optimize performance. Therefore, perhaps any B cell
could respond to any antigen, but there may be some best fit advantage conferred
to those with closer p values. It is also possible that there are genomic constraints
that keep antigens with response p values in the robust range. Antigens, though, are
myriad and often highly mutable themselves, so we need to allow for the possibility
that they can present a range of optimal response p.
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Figure 8. Graphs of the KS statistic between R
(
c1, ·, p1, N−1
)
and R
(
c1, ·, p2, N−1
)
for p1 = 0.71, p1 = 0.81, p1 = 0.91 and p1 =
0.992 and p2 ∈ [0.4, 0.9999]
If p were coded in the Ig gene itself, then each time there is a mutation in the code,
there would be a non-zero probability that p would change as well. This may be
understood by the system as a new likelihood for the probability of the next global
jump. The observed mutation distribution during hypermutation is not uniform,
because if it were, the predicted degeneracy rate would be too high. Instead it
has evolved to target certain sites preferentially [MTBC+98, DFBL98, FDL99b,
FDL99a, CK00]. Intrinsic hotspots are usually shown to be hotspots independent
of antigenic selection, and concentrated in the CDRs, often in an overlapping fashion
[DBB+97, Elg96]. In experiments with a light chain transgene, silent mutation in
one part of the gene resulted in loss of a hotspot motif and in the appearance and loss
of hotspots in other areas [GM96]. This argues for a higher order template as well
as an evolving dynamic with loss and acquisition of mutations. This higher order
structure may be conferred by DNA folding, or perhaps DNA–protein interactions
[GM96]. Therefore, the optimizing of the mutation frequency of p may also emerge
from the V genes themselves, both in their structure and code.
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7. Conclusion
The system under consideration is complex and dynamic and operates as an or-
chestra of signals, threshold concentrations, feedback loops and other self regulating
behaviors. It must be responsive to the environment, but avoid extreme sensitivity
to initial conditions, so that its robust qualities can be appreciated. The disequi-
librium nature of our performance criterion necessitates a computational burden
that would make it impractical to exhibit this robustness reliably through simu-
lation from first principles. Our model does not attempt to capture the details,
or make ad hoc assumptions, but incorporates biologically sound parameters into
a simplified framework that yields a deeper result – the robust and fundamental
characteristic of the system that is realized in the trade-off represented by p.
We can now better appreciate how the organism manages to successfully face
myriad antigenic challenges. This ability appears to arise naturally; it is not a
constant battle for the organism but the natural consequence of its complexity.
Appreciating that antigens and antibodies have co-evolved, each responding to the
adaptive pressures of the other, it is also the nature of the antigens that helped
shape the evolution of p in this system. The information stored in such molecules
figures prominently into the naturally arising behaviors we observe. There is am-
ple evidence for coding bias in the V gene [DBB+97, FDL99a, CK00], even sug-
gesting that as a result of co-evolution, there exist “dominant epitopes” among
pathogens with corresponding pre-selected effectors in the response population. In
other words, perhaps certain V genes have evolved to be more mutable, and others
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Figure 10. Contour plot of Figure 9 (log(1 − p) on both axes)
showing the two “islands” of high distributional stability (one at
low values of p and one at high values of p), separated by the
“saddle-point” around p = 0.98
more robust [OT99, FAFS+99, CK00]. The response and responders are modified
accordingly depending on the feedback signals received. Along with the idea of
feedback is the theme of the cells “sensing” their environment, both external and
internal, and monitoring their performance in order to adjust to these signals. Our
model responds to such a phenomenon- there is no all-or-nothing response, but
rather a modulation based on gradients.
While the mutator mechanism is still not understood, certain transcriptional el-
ements appear to be necessary for mutation in both heavy and light chain genes
[FJR98, NKJ+98, DF98, BRZ+98], although additional, novel molecular mecha-
nisms need to be considered. Evidence that multiple Ig receptors can be expressed
on the surface of an individual B cell [KRL+00] may allow the possibility of such a
novel molecular mechanism being employed in affinity maturation as well. A reverse
transcription model has already been suggested [BRZ+98] and with recent evidence
that mRNA can travel intercellularly, thus altering the phenotype of neighboring
cells, makes the possibility of alternate expression paradigms intriguing. No exper-
imental evidence exists yet to support this in the context of affinity maturation,
but our model does not preclude such novel mechanisms.
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Finally, the complete appreciation of the significance of p may extend to more
global control mechanisms operating throughout the genome, the actions of which
may be observed on all scales of evolution.
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